Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for gp120s
Most Correlated Studies
- Neuronal damage by HIV glycoprotein 120 expression in CCR5 KO and wildtype mice
- Dorsal root ganglia from rats modeling neuropathic pain by treatment with gp120 with ddC
- PBMCs of donors immunized with RV144 (ALVAC-gp120) HIV vaccine showing high or low ADCP
- Acute monocytic leukemia (AML) THP-1 cells HIV gp120 or LPS stimulated following SB203580 treatment
- Whole blood from macaques vaccinated with SIVgp96Ig and then challenged with SIVmac251
Most Relevant Literature
- Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120.
- P2Y12-mediated HIV gp120 and ddC-induced neuropathic pain improved by esculin.
- HIV-1 gp120 Interactions with Nicotine Modulate Mitochondrial Network Properties and Amyloid Release…
- Quercetin mitigates HIV-1 gp120-induced rat astrocyte neurotoxicity via promoting G3BP1 disassembly …
- The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding o…
Most Relevant Clinical Trials
- Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
- Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)
- Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfec…
- A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability…
- Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV…
